July 23, 2026 · Journal of the American Society of Nephrology : JASN · DOI: 10.1681/ASN.0000001195

Anti-podocin and Anti-KIRREL1 Antibodies and Steroid Resistance, FSGS, and Disease Recurrence after Transplantation in Autoimmune Podocytopathies

Listen to this summary

This study investigates the clinical implications of anti-podocin and anti-KIRREL1 antibodies in patients with autoimmune podocytopathies, particularly their association with steroid resistance, focal segmental glomerulosclerosis (FSGS), and disease recurrence after kidney transplantation. The authors found that these antibodies correlate with poorer outcomes, including steroid resistance and higher rates of post-transplant recurrence, while isolated anti-nephrin antibodies were linked to better prognoses. Overall, the research highlights the importance of identifying specific autoantibodies to predict disease progression and treatment responses in affected patients.

Valentina Raglianti, Maria Lucia Angelotti, Luigi Cirillo, Francesca Becherucci, Letizia De Chiara, Benedetta Mazzinghi, Antea Di Lorenzo, Giulia Salvatore, Giulia Antonelli, Carolina Conte, Maria Elena Melica, Viviana Palazzo, Anna Julie Peired, Tommaso Dafichi, Paula Diaz-Bulnes, Aurora Gnagni, Luca Malatesta, Marco Allinovi, Leonardo Caroti, Anna Manonelles, Josep Maria Cruzado, Domenico Giannese, Chiara Somma, Tommaso Mazzierli, Baerbel Lange-Sperandio, Federica Baccini, Laura Lasagni, Elena Lazzeri, Hans-Joachim Anders, Paola Romagnani

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play